FTXH holdings

All 51 positions of First Trust Nasdaq Pharmaceuticals ETF.

Download CSV

Positions

Top 10 weight

53.1%

Effective holdings

25.4

1 / sum of squared weights

In stocks

99.9%

In bonds

0.0%

Outside the US

4.4%

Asset mix

Equity99.9%
Cash0.1%

Sectors

96% of stocks classified

Health Care92.7%
Technology2.8%

Countries

United States95.5%
Ireland3.8%
Bermuda0.6%

Holdings

#	Holding	Type	Weight	Value	Shares / par	Country
1	LLYEli Lilly & Co.	Equity	7.77%	$2.8M	2,347	US
2	ABBVABBVIE INC.	Equity	7.39%	$2.7M	10,640	US
3	MRKMerck & Co., Inc.	Equity	7.07%	$2.6M	19,942	US
4	JNJJohnson & Johnson	Equity	6.96%	$2.5M	9,939	US
5	BMYBristol-Myers Squibb Co.	Equity	6.29%	$2.3M	39,590	US
6	BIIBBiogen Inc. Common Stock	Equity	3.84%	$1.4M	6,436	US
7	VTRSViatris Inc. Common Stock	Equity	3.62%	$1.3M	82,694	US
8	CAHCardinal Health, Inc.	Equity	3.53%	$1.3M	5,386	US
9	VRTXVertex Pharmaceuticals Inc	Equity	3.41%	$1.2M	2,485	US
10	AMGNAmgen Inc	Equity	3.18%	$1.2M	3,181	US
11	PFEPfizer Inc.	Equity	2.97%	$1.1M	44,652	US
12	GILDGilead Sciences Inc	Equity	2.89%	$1.0M	8,289	US
13	UTHRUnited Therapeutics Corp	Equity	2.72%	$987K	1,822	US
14	REGNRegeneron Pharmaceuticals Inc	Equity	2.72%	$985K	1,579	US
15	JAZZ PHARMACEUTICALS PLC	Equity	2.49%	$901K	3,741	IE
16	INCYIncyte Genomics Inc	Equity	2.39%	$867K	7,648	US
17	ILMNIllumina Inc	Equity	1.98%	$719K	4,088	US
18	ZTSZOETIS INC.	Equity	1.87%	$677K	9,417	US
19	EXELExelixis Inc	Equity	1.72%	$625K	11,488	US
20	CRLCharles River Laboratories International, Inc.	Equity	1.49%	$539K	2,377	US
21	MEDPMedpace Holdings, Inc. Common Stock	Equity	1.41%	$512K	966	US
22	PTCTPTC Therapeutics, Inc.	Equity	1.37%	$497K	6,091	US
23	NBIXNeurocrine Biosciences Inc	Equity	1.37%	$495K	2,939	US
24	ALKERMES PLC	Equity	1.35%	$491K	9,366	IE
25	HALOHalozyme Therapeutics, Inc.	Equity	1.21%	$438K	5,593	US
26	BMRNBioMarin Pharmaceuticals Inc	Equity	1.11%	$404K	7,061	US
27	TWSTTwist Bioscience Corporation Common Stock	Equity	1.03%	$372K	3,619	US
28	SYRESpyre Therapeutics, Inc. Common Stock	Equity	0.97%	$351K	3,948	US
29	TVTXTravere Therapeutics, Inc. Common Stock	Equity	0.89%	$324K	5,700	US
30	TGTXTG Therapeutics, Inc.	Equity	0.86%	$310K	5,643	US
31	ELANElanco Animal Health Incorporated Common Stock	Equity	0.83%	$300K	12,210	US
32	TXG10x Genomics, Inc. Class A Common Stock	Equity	0.78%	$282K	7,367	US
33	GHGuardant Health, Inc. Common Stock	Equity	0.75%	$271K	1,808	US
34	LGNDLigand Pharmaceuticals Inc.	Equity	0.75%	$271K	856	US
35	RCUSArcus Biosciences, Inc.	Equity	0.71%	$257K	8,336	US
36	AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	Equity	0.69%	$251K	14,511	US
37	ARWRArrowhead Research Corporation	Equity	0.66%	$238K	2,918	US
38	CPRXCatalyst Pharmaceutical Inc.	Equity	0.64%	$231K	7,357	US
39	KRYSKrystal Biotech, Inc. Common Stock	Equity	0.63%	$229K	616	US
40	PTGXProtagonist Therapeutics, Inc	Equity	0.62%	$226K	1,844	US
41	MRNAModerna, Inc. Common Stock	Equity	0.61%	$222K	3,170	US
42	MIRMMirum Pharmaceuticals, Inc. Common Stock	Equity	0.59%	$215K	1,840	US
43	KYMRKymera Therapeutics, Inc. Common Stock	Equity	0.59%	$213K	1,859	US
44	ROIVANT SCIENCES LTD	Equity	0.57%	$208K	5,868	BM
45	ACADAcadia Pharmaceuticals Inc.	Equity	0.48%	$175K	6,914	US
46	IONSIonis Pharmaceuticals, Inc. Common Stock	Equity	0.46%	$166K	2,093	US
47	ARQTArcutis Biotherapeutics, Inc. Common Stock	Equity	0.46%	$165K	6,296	US
48	ALNYAlnylam Pharmaceuticals, Inc.	Equity	0.42%	$154K	510	US
49	SUPNSupernus Pharmaceuticals, Inc.	Equity	0.40%	$144K	3,103	US
50	TARSTarsus Pharmaceuticals, Inc. Common Stock	Equity	0.39%	$142K	2,249	US
51	DREYFUS GOVERNMENT CASH MANAGEMENT FUNDS	Cash	0.10%	$38K	37,778	US

Find which other funds hold a stock by opening it and choosing "ETFs holding".

Position changes between reports

Action	Holding	Weight before	Weight after	Shares vs flows	Between reports
Decrease	PFEPfizer Inc.	6.19%	3.85%	−38.3%	Dec 31, 2025 → Mar 31, 2026 SEC
Increase	LLYEli Lilly & Co.	4.52%	6.62%	+91.8%	Dec 31, 2025 → Mar 31, 2026 SEC
Increase	ZTSZoetis Inc.	2.48%	3.41%	+64.4%	Dec 31, 2025 → Mar 31, 2026 SEC
Decrease	CAHCardinal Health, Inc.	4.25%	3.49%	−10.6%	Dec 31, 2025 → Mar 31, 2026 SEC
Decrease	ARWRArrowhead Pharmaceuticals Inc	1.26%	0.56%	−47.3%	Dec 31, 2025 → Mar 31, 2026 SEC
Increase	INCYIncyte Corporation.	1.54%	2.21%	+68.7%	Dec 31, 2025 → Mar 31, 2026 SEC
Exit	BBIOBridgebio Pharma Inc	0.62%	—	—	Dec 31, 2025 → Mar 31, 2026 SEC
Exit	NEWAMSTERDAM PHARMA CO NV	0.61%	—	—	Dec 31, 2025 → Mar 31, 2026 SEC
New position	SYRESpyre Therapeutics Inc	—	0.61%	—	Dec 31, 2025 → Mar 31, 2026 SEC
Exit	MDGLMadrigal Pharmaceuticals Inc	0.56%	—	—	Dec 31, 2025 → Mar 31, 2026 SEC
New position	RCUSARCUS BIOSCIENCES INC	—	0.55%	—	Dec 31, 2025 → Mar 31, 2026 SEC
Exit	INSMInsmed Inc	0.54%	—	—	Dec 31, 2025 → Mar 31, 2026 SEC
New position	TWSTTwist Bioscience Corporation	—	0.53%	—	Dec 31, 2025 → Mar 31, 2026 SEC
New position	TVTXTravere Therapeutics Inc	—	0.52%	—	Dec 31, 2025 → Mar 31, 2026 SEC
Increase	NBIXNeurocrine Biosciences Inc	0.68%	1.19%	+110.7%	Dec 31, 2025 → Mar 31, 2026 SEC
New position	Roivant Sciences Ltd	—	0.50%	—	Dec 31, 2025 → Mar 31, 2026 SEC
New position	MRNAModerna Inc	—	0.49%	—	Dec 31, 2025 → Mar 31, 2026 SEC
New position	TARSTarsus Pharmaceuticals Inc	—	0.48%	—	Dec 31, 2025 → Mar 31, 2026 SEC
New position	TXG10X Genomics Inc	—	0.48%	—	Dec 31, 2025 → Mar 31, 2026 SEC
New position	KYMRKymera Therapeutics Inc	—	0.47%	—	Dec 31, 2025 → Mar 31, 2026 SEC
New position	ARQTARCUTIS BIOTHERAPEUTICS INC	—	0.45%	—	Dec 31, 2025 → Mar 31, 2026 SEC
Exit	ADMAADMA Biologics Inc	0.44%	—	—	Dec 31, 2025 → Mar 31, 2026 SEC
Exit	RYTMRhythm Pharmaceuticals Inc	0.43%	—	—	Dec 31, 2025 → Mar 31, 2026 SEC
Increase	ABBVAbbVie Inc.	6.69%	7.10%	+24.9%	Dec 31, 2025 → Mar 31, 2026 SEC
Exit	PBHPrestige Consumer Healthcare I	0.40%	—	—	Dec 31, 2025 → Mar 31, 2026 SEC
Exit	TEMTempus AI Inc	0.33%	—	—	Dec 31, 2025 → Mar 31, 2026 SEC
Increase	HALOHalozyme Therapeutics Inc	0.79%	1.11%	+64.0%	Dec 31, 2025 → Mar 31, 2026 SEC
Exit	Perrigo Co PLC	0.32%	—	—	Dec 31, 2025 → Mar 31, 2026 SEC
Decrease	IONSIonis Pharmaceuticals, Inc.	0.78%	0.48%	−26.9%	Dec 31, 2025 → Mar 31, 2026 SEC
Decrease	Jazz Pharmaceuticals PLC	2.46%	2.17%	−11.3%	Dec 31, 2025 → Mar 31, 2026 SEC
Increase	Alkermes PLC	0.73%	1.02%	+23.7%	Dec 31, 2025 → Mar 31, 2026 SEC
Increase	MEDPMedpace Holdings Inc.	1.15%	1.42%	+61.6%	Dec 31, 2025 → Mar 31, 2026 SEC
Decrease	KRYSKrystal Biotech Inc	0.70%	0.49%	−25.5%	Dec 31, 2025 → Mar 31, 2026 SEC
Exit	CORTCorcept Therapeutics Inc	0.21%	—	—	Dec 31, 2025 → Mar 31, 2026 SEC
Decrease	ELANElanco Animal Health Inc	1.08%	0.90%	−12.0%	Dec 31, 2025 → Mar 31, 2026 SEC
Decrease	AMRXAmneal Pharmaceuticals Inc	0.72%	0.55%	−13.3%	Dec 31, 2025 → Mar 31, 2026 SEC
Increase	EXELExelixis, Inc.	1.34%	1.51%	+28.7%	Dec 31, 2025 → Mar 31, 2026 SEC
Increase	BMRNBiomarin Pharmaceutical Inc.	1.07%	1.22%	+34.9%	Dec 31, 2025 → Mar 31, 2026 SEC
Increase	TGTXTG Therapeutics Inc	0.43%	0.57%	+35.7%	Dec 31, 2025 → Mar 31, 2026 SEC
Increase	ALNYAlnylam Pharmaceuticals Inc.	0.37%	0.52%	+87.4%	Dec 31, 2025 → Mar 31, 2026 SEC
Increase	MIRMMirum Pharmaceuticals Inc.	0.45%	0.52%	+11.5%	Dec 31, 2025 → Mar 31, 2026 SEC
Increase	CPRXCatalyst Pharmaceuticals Inc.	0.49%	0.56%	+20.7%	Dec 31, 2025 → Mar 31, 2026 SEC
Increase	ACADAcadia Pharmaceuticals Inc	0.43%	0.47%	+47.3%	Dec 31, 2025 → Mar 31, 2026 SEC
Increase	LGNDLigand Pharmaceuticals Incorporated	0.49%	0.52%	+13.5%	Dec 31, 2025 → Mar 31, 2026 SEC
Increase	SUPNSupernus Pharmaceuticals, Inc	0.46%	0.49%	+14.7%	Dec 31, 2025 → Mar 31, 2026 SEC
Decrease	PTGXProtagonist Therapeutics Inc	0.62%	0.60%	−10.8%	Dec 31, 2025 → Mar 31, 2026 SEC

Share-count changes are measured after removing what creations and redemptions explain.

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.